CLINICAL_TRIALS
trial_result
· 2024-07-10
Clinical Trial Update: Temsirolimus for Relapsed/Refractory Hodgkin's Lymphoma [Phase 2]
Summary
A Phase 2 trial of temsirolimus for relapsed/refractory Hodgkin lymphoma was terminated; the update does not provide trial results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Loyola University | Conditions: Hodgkin's Lymphoma | Phase 2 | Status: TERMINATED